Study population characteristics of the general population comparators, untreated sarcoidosis patients and corticosteroid-treated sarcoidosis patients
| General population comparators | Untreated sarcoidosis | Corticosteroid-treated sarcoidosis | |
| Subjects | 61 297 | 3448 | 2306 |
| Survival time years | 3.5 (1.7–5.5) | 3.3 (1.7–5.4) | 3.5 (1.5–5.5) |
| Age years | 48.3 (38.3–61.0) | 48.4 (38.4–61.0) | 47.2 (37.2–60.4) |
| Sex | |||
| Female | 27 470 (44.8) | 1571 (45.6) | 954 (41.4) |
| Male | 33 827 (55.2) | 1877 (54.4) | 1 352 (58.6) |
| Family history of diabetes | 15 284 (24.9) | 946 (27.4) | 649 (28.1) |
| Education | |||
| ≤9 years | 12 069 (19.7) | 633 (18.4) | 478 (20.7) |
| 10–12 years | 28 297 (46.2) | 1669 (48.4) | 1 192 (51.7) |
| ≥13 years | 20 185 (32.9) | 1098 (31.8) | 620 (26.9) |
| Missing | 746 (1.2) | 48 (1.4) | 16 (0.7) |
| Health region | |||
| Stockholm | 12 586 (20.5) | 839 (24.3) | 349 (15.1) |
| Uppsala-Örebro | 13 331 (21.7) | 717 (20.8) | 532 (23.1) |
| West | 10 985 (17.9) | 607 (17.6) | 430 (18.6) |
| South | 10 433 (17.0) | 526 (15.3) | 452 (19.6) |
| Southeast | 7114 (11.6) | 337 (9.8) | 322 (14.0) |
| North | 6848 (11.2) | 422 (12.2) | 221 (9.6) |
| Country of birth | |||
| Outside Nordics | 7568 (12.3) | 366 (10.6) | 204 (8.8) |
| Inside Nordics | 53 483 (87.3) | 3066 (88.9) | 2097 (90.9) |
| Missing | 246 (0.4) | 16 (0.5) | 5 (0.2) |
Data are presented as n, median (interquartile range) or n (%).